| Year |
Citation |
Score |
| 2024 |
Wen D, Meng C, Feng Y, Shen L, Liu Y, Sun W, Chen G, Wu C. Syringaldehyde Exhibits Antibacterial and Antioxidant Activities against Infection. Microorganisms. 12. PMID 38399751 DOI: 10.3390/microorganisms12020348 |
0.3 |
|
| 2020 |
Zhang Q, Wang Y, Qi C, Shen L, Li J. Clinical trial analysis of 2019-nCoV therapy registered in China. Journal of Medical Virology. PMID 32108352 DOI: 10.1002/jmv.25733 |
0.321 |
|
| 2012 |
Shamay M, Liu J, Li R, Liao G, Shen L, Greenway M, Hu S, Zhu J, Xie Z, Ambinder RF, Qian J, Zhu H, Hayward SD. A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. Journal of Virology. 86: 5179-91. PMID 22379092 DOI: 10.1128/Jvi.00169-12 |
0.306 |
|
| 2012 |
Jilek BL, Zarr M, Sampah ME, Rabi SA, Bullen CK, Lai J, Shen L, Siliciano RF. A quantitative basis for antiretroviral therapy for HIV-1 infection. Nature Medicine. 18: 446-51. PMID 22344296 DOI: 10.1038/Nm.2649 |
0.759 |
|
| 2012 |
Sampah ME, Jilek B, Shen L, Rabi A, Zarr M, Bullen CK, Lai J, Siliciano R. Quantifying combination ARV drug effects in wild type and resistant HIV-1 infection F1000research. 3. DOI: 10.7490/F1000Research.1089961.1 |
0.769 |
|
| 2011 |
Shen L, Rabi SA, Sedaghat AR, Shan L, Lai J, Xing S, Siliciano RF. A critical subset model provides a conceptual basis for the high antiviral activity of major HIV drugs. Science Translational Medicine. 3: 91ra63. PMID 21753122 DOI: 10.1126/Scitranslmed.3002304 |
0.821 |
|
| 2011 |
Sampah ME, Shen L, Jilek BL, Siliciano RF. Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance. Proceedings of the National Academy of Sciences of the United States of America. 108: 7613-8. PMID 21502494 DOI: 10.1073/Pnas.1018360108 |
0.734 |
|
| 2011 |
McMahon MA, Parsons TL, Shen L, Siliciano JD, Siliciano RF. Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses. Journal of Virology. 85: 4618-22. PMID 21325417 DOI: 10.1128/Jvi.02423-10 |
0.776 |
|
| 2011 |
Rabi SA, O'Connell KA, Nikolaeva D, Bailey JR, Jilek BL, Shen L, Page KR, Siliciano RF, Blankson JN. Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. Journal of Virology. 85: 979-86. PMID 21068257 DOI: 10.1128/Jvi.01721-10 |
0.758 |
|
| 2010 |
Bellows ML, Taylor MS, Cole PA, Shen L, Siliciano RF, Fung HK, Floudas CA. Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework. Biophysical Journal. 99: 3445-53. PMID 21081094 DOI: 10.1016/J.Bpj.2010.09.050 |
0.574 |
|
| 2010 |
Shen L, Siliciano RF. Achieving a quantitative understanding of antiretroviral drug efficacy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 51: 1105-6; author reply. PMID 20925507 DOI: 10.1086/656688 |
0.675 |
|
| 2009 |
McMahon MA, Shen L, Siliciano RF. New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo. Current Opinion in Infectious Diseases. 22: 574-82. PMID 19841584 DOI: 10.1097/Qco.0B013E328332C54D |
0.835 |
|
| 2009 |
Shen L, Rabi SA, Siliciano RF. A novel method for determining the inhibitory potential of anti-HIV drugs. Trends in Pharmacological Sciences. 30: 610-6. PMID 19837466 DOI: 10.1016/J.Tips.2009.09.003 |
0.74 |
|
| 2009 |
Yang HC, Shen L, Siliciano RF, Pomerantz JL. Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 106: 6321-6. PMID 19336585 DOI: 10.1073/Pnas.0809536106 |
0.752 |
|
| 2008 |
Shen L, Siliciano RF. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. The Journal of Allergy and Clinical Immunology. 122: 22-8. PMID 18602567 DOI: 10.1016/J.Jaci.2008.05.033 |
0.671 |
|
| 2008 |
Zhou Y, Shen L, Yang HC, Siliciano RF. Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription. Journal of Virology. 82: 9154-63. PMID 18596085 DOI: 10.1128/Jvi.00773-08 |
0.709 |
|
| 2008 |
Shen L, Peterson S, Sedaghat AR, McMahon MA, Callender M, Zhang H, Zhou Y, Pitt E, Anderson KS, Acosta EP, Siliciano RF. Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nature Medicine. 14: 762-6. PMID 18552857 DOI: 10.1038/Nm1777 |
0.848 |
|
| 2008 |
Sedaghat AR, Dinoso JB, Shen L, Wilke CO, Siliciano RF. Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. Proceedings of the National Academy of Sciences of the United States of America. 105: 4832-7. PMID 18362342 DOI: 10.1073/Pnas.0711372105 |
0.82 |
|
| 2007 |
McMahon MA, Jilek BL, Brennan TP, Shen L, Zhou Y, Wind-Rotolo M, Xing S, Bhat S, Hale B, Hegarty R, Chong CR, Liu JO, Siliciano RF, Thio CL. The HBV drug entecavir - effects on HIV-1 replication and resistance. The New England Journal of Medicine. 356: 2614-21. PMID 17582071 DOI: 10.1056/Nejmoa067710 |
0.791 |
|
| Show low-probability matches. |